Fertility and endocrine treatments often include human chorionic gonadotropin (hCG). Clinicians use it to trigger ovulation or support testosterone production. Patients may encounter different brands, including Pregnyl. Understanding where hCG fits in care, how it is dosed, and what to watch for can reduce confusion.
In the pharmacy supply chain, cross-border options exist for some patients. One example is BorderFreeHealth . BorderFreeHealth connects U.S. patients with licensed Canadian partner pharmacies. Where required, prescription details are verified with the prescriber prior to dispensing by the pharmacy. We support access to cash-pay, cross-border prescription options for patients without insurance, subject to eligibility and jurisdiction.
What hCG does in the body
hCG is a hormone that activates the luteinizing hormone (LH) receptor. In ovarian cycles, it completes the final stage of egg maturation and triggers ovulation. It also helps the corpus luteum produce progesterone after ovulation. In testes, hCG stimulates Leydig cells to make testosterone. Over time, and often with added FSH-based therapy, it can support sperm production when the pituitary signal is low.
hCG products are either urinary-derived or recombinant. Some formulations, including certain branded options such as Pregnyl, are urinary-derived and supplied as a powder with a sterile diluent. Depending on labeling and local practice, injections may be given intramuscularly or subcutaneously.
Clinical situations where hCG is used
Ovulation trigger and assisted reproduction. Fertility teams use hCG to trigger ovulation once follicles reach a target size. This is common in timed intercourse, intrauterine insemination (IUI), and in vitro fertilization (IVF). In IVF, timing is closely coordinated with egg retrieval. hCG does not help when the ovaries cannot respond (for example, in primary ovarian failure). Some older protocols used hCG for luteal support, but progesterone is now more common because hCG may increase ovarian hyperstimulation risk.
Male hypogonadotropic hypogonadism. When the pituitary signal is low, hCG can raise testosterone and, with time and often with FSH or hMG, support spermatogenesis. If pregnancy is the goal, treatment durations are measured in months. Off-label use with testosterone therapy exists to support testicular function and fertility potential. That approach requires specialist oversight and individualized risk–benefit discussion.
Cryptorchidism in children. In selected prepubertal boys with undescended testes, hCG may be used under pediatric endocrine or urology care. Outcomes vary by age, anatomy, and laterality. Many children still need surgery, and specialist follow-up is essential.
Not for weight loss or performance. hCG should not be used for weight loss. This practice is unsafe and unsupported by evidence. Many sports organizations prohibit hCG; athletes should review anti-doping rules.
Dosing approaches and administration
Doses and schedules vary by diagnosis, treatment goals, and product labeling. The prescriber’s individualized instructions always take priority. Common clinical approaches include:
• Ovulation trigger (adults): A single intramuscular or subcutaneous dose is typically used, often 5,000–10,000 IU. The exact dose depends on follicle number, estradiol levels, body size, and risk of ovarian hyperstimulation. Timing is precise and set by the clinic.
• Male hypogonadotropic hypogonadism: hCG is often given two or three times weekly, commonly in the 500–2,000 IU range per dose. Courses are long and may be combined with FSH-based therapy when pregnancy is the goal.
• Pediatric cryptorchidism: Protocols vary widely. Short courses several times per week over weeks may be considered by pediatric subspecialists.
How it is given. Many hCG products come as a powder and sterile diluent. A clinician or trained patient mixes the dose and injects it as labeled (intramuscular or subcutaneous). Rotate injection sites. Do not share or reuse needles. Follow label and pharmacy instructions for storage and handling; stability after mixing is limited. If a dose is missed, follow your clinic’s protocol rather than doubling a dose.
Safety, side effects, and warnings
• Common effects: Injection site pain, redness, or bruising; headache; fatigue; mood changes; acne; mild swelling.
• In women: hCG can contribute to ovarian hyperstimulation syndrome (OHSS) in high-risk cycles. Warning signs include severe pelvic or abdominal pain, rapid weight gain, shortness of breath, or reduced urination. hCG-supported cycles also raise the chance of multiple pregnancy.
• In men: Possible gynecomastia, acne, fluid retention, testicular discomfort, or mood changes. If used alongside testosterone therapy, clinicians often monitor estradiol and hematocrit.
• Testing interference: An hCG injection can cause a positive pregnancy test for 7–14 days. Clinics time testing to avoid false positives.
• Contraindications and cautions: Known hypersensitivity; hormone-sensitive tumors (for example, some prostate or breast cancers); uncontrolled thyroid or adrenal disease; precocious puberty; ovarian cysts not due to polycystic ovary syndrome. Not effective in primary ovarian failure.
• When to seek urgent care: Severe pelvic or abdominal pain, chest pain, shortness of breath, unilateral leg swelling, heavy vaginal bleeding, confusion, or sudden severe headache.
Monitoring and follow-up
In fertility care, teams track follicle growth and estradiol with ultrasound and blood tests. After a trigger dose, timing of intercourse, IUI, or retrieval is planned. Clinics watch for OHSS and advise when to test for pregnancy to avoid hCG-related false positives.
In male care, monitoring often includes testosterone, estradiol, LH/FSH, and hematocrit. When fertility is the goal, semen analysis is repeated after several months, since sperm production responds slowly.
In pediatrics, follow-up exams assess testicular position and growth. If response is incomplete, surgical referral is common.
An informational overview on hCG in care pathways is available for background reading.
Access, coverage, and care navigation
hCG is a prescription medicine, often dispensed by specialty or partner pharmacies. Clinics may coordinate with multiple pharmacies to match clinical needs, patient preferences, and jurisdictional rules. Cross-border models exist in which organizations connect U.S. patients with licensed Canadian partner pharmacies. In these pathways, prescription details are verified with the prescriber where required by the dispensing pharmacy, and cash-pay options may be available to eligible, uninsured patients, subject to jurisdiction.
Regardless of the dispensing route, the pharmacy’s role includes verifying the prescription, providing product-specific handling guidance, and answering administration questions. Patients benefit when clinics, pharmacies, and labs share clear timelines for dosing, monitoring, and follow-up testing.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.
Summary: hCG activates the LH receptor to trigger ovulation and stimulate testosterone production. It has established roles in fertility and endocrine care, with dosing and monitoring tailored to the condition and product. Safety focuses on preventing OHSS in women, tracking hormone effects in men, and ensuring careful pediatric oversight. Clear instructions, appropriate monitoring, and coordination across the care team support safe, effective use.